Geranylgeranyltransferase type 1

From WikiMD's Food, Medicine & Wellness Encyclopedia

Geranylgeranyltransferase type 1 (GGTase-I) is an enzyme that plays a crucial role in the post-translational modification of proteins through a process known as prenylation. This modification involves the attachment of geranylgeranyl groups to the cysteine residues of specific protein substrates, a critical step for their proper localization and function within the cell. GGTase-I is particularly important in the modification of small GTPases, which are involved in various cellular processes including signal transduction, cell growth, and differentiation.

Function[edit | edit source]

GGTase-I specifically catalyzes the transfer of a 20-carbon geranylgeranyl moiety from geranylgeranyl pyrophosphate (GGPP) to the cysteine residues at the C-terminus of target proteins in a reaction that requires the presence of a CAAX motif (where C is cysteine, A is an aliphatic amino acid, and X is any amino acid). This modification increases the hydrophobicity of the target protein, facilitating its association with cell membranes and thus influencing its activity and interactions within the cell.

Structure[edit | edit source]

The enzyme is a heterodimer composed of an alpha (α) subunit and a beta (β) subunit. The α subunit is shared with another enzyme, farnesyltransferase, while the β subunit is unique to GGTase-I. This composition is critical for the enzyme's specificity towards its substrates.

Clinical Significance[edit | edit source]

Alterations in the activity of GGTase-I have been implicated in various diseases, including cancer. The enzyme's role in modifying proteins that regulate cell growth and survival makes it a potential target for therapeutic intervention. Inhibitors of GGTase-I are being explored as anticancer agents, with the rationale that blocking the prenylation of oncogenic proteins might suppress tumor growth and progression.

Research[edit | edit source]

Research into GGTase-I has focused on understanding its substrate specificity, mechanism of action, and role in disease. Studies have also been directed towards developing specific inhibitors that can selectively target GGTase-I without affecting other enzymes involved in prenylation, aiming to minimize potential side effects.

See Also[edit | edit source]

References[edit | edit source]

Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD